BioMarin Pharmaceutical raised to Strong Buy from Outperform by Raymond James
BMRN•Raymond James raised its rating on BioMarin Pharmaceutical Inc. to Strong Buy from Outperform.
Related News
Enovix rises on higher Q3 preliminary revenue
ENVX•
Redfin: US pending home sales slide to lowest since 2014 as mortgage rates top 7%
RDFN•
Nexgel begins 1-for-20 reverse stock split trading on Nasdaq
NXGL•
AeroVironment says Halo_Shield counter-UAS system performs strongly in T-REX 26-3 trials
AVAV•
Oscar Health schedules third-quarter earnings call
OSCR•